O12.4. EFFECTS OF THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST EXENATIDE ON BONE STATUS IN OBESE, NON-DIABETIC, ANTIPSYCHOTIC-TREATED SCHIZOPHRENIA SPECTRUM PATIENTS

Research output: Contribution to journal › Conference abstract in journal › Research

Standard

O12.4. EFFECTS OF THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST EXENATIDE ON BONE STATUS IN OBESE, NON-DIABETIC, ANTIPSYCHOTIC-TREATED SCHIZOPHRENIA SPECTRUM PATIENTS. / Eriksson, Robert; Broberg, Brian V; Ishoy, Pelle Lau; Bak, Nikolaj; Andersen, Ulrik B; Jørgensen, Niklas R; Knop, Filip K; Ebdrup, Bjorn.

In: Schizophrenia Bulletin, Vol. 45, No. Suppl. 2, 2019, p. S198-S199.

Research output: Contribution to journal › Conference abstract in journal › Research

Harvard

Eriksson, R, Broberg, BV, Ishoy, PL, Bak, N, Andersen, UB, Jørgensen, NR, Knop, FK & Ebdrup, B 2019, 'O12.4. EFFECTS OF THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST EXENATIDE ON BONE STATUS IN OBESE, NON-DIABETIC, ANTIPSYCHOTIC-TREATED SCHIZOPHRENIA SPECTRUM PATIENTS', Schizophrenia Bulletin, vol. 45, no. Suppl. 2, pp. S198-S199. https://doi.org/10.1093/schbul/sbz021.268

APA

Eriksson, R., Broberg, B. V., Ishoy, P. L., Bak, N., Andersen, U. B., Jørgensen, N. R., Knop, F. K., & Ebdrup, B. (2019). O12.4. EFFECTS OF THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST EXENATIDE ON BONE STATUS IN OBESE, NON-DIABETIC, ANTIPSYCHOTIC-TREATED SCHIZOPHRENIA SPECTRUM PATIENTS. Schizophrenia Bulletin, 45(Suppl. 2), S198-S199. https://doi.org/10.1093/schbul/sbz021.268

Vancouver

Eriksson R, Broberg BV, Ishoy PL, Bak N, Andersen UB, Jørgensen NR et al. O12.4. EFFECTS OF THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST EXENATIDE ON BONE STATUS IN OBESE, NON-DIABETIC, ANTIPSYCHOTIC-TREATED SCHIZOPHRENIA SPECTRUM PATIENTS. Schizophrenia Bulletin. 2019;45(Suppl. 2):S198-S199. https://doi.org/10.1093/schbul/sbz021.268

Author

Eriksson, Robert ; Broberg, Brian V ; Ishoy, Pelle Lau ; Bak, Nikolaj ; Andersen, Ulrik B ; Jørgensen, Niklas R ; Knop, Filip K ; Ebdrup, Bjorn. / O12.4. EFFECTS OF THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST EXENATIDE ON BONE STATUS IN OBESE, NON-DIABETIC, ANTIPSYCHOTIC-TREATED SCHIZOPHRENIA SPECTRUM PATIENTS. In: Schizophrenia Bulletin. 2019 ; Vol. 45, No. Suppl. 2. pp. S198-S199.

Bibtex

@article{201346edb4654e3f9c4345210d5fb7d1,
title = "O12.4. EFFECTS OF THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST EXENATIDE ON BONE STATUS IN OBESE, NON-DIABETIC, ANTIPSYCHOTIC-TREATED SCHIZOPHRENIA SPECTRUM PATIENTS",
author = "Robert Eriksson and Broberg, {Brian V} and Ishoy, {Pelle Lau} and Nikolaj Bak and Andersen, {Ulrik B} and J{\o}rgensen, {Niklas R} and Knop, {Filip K} and Bjorn Ebdrup",
year = "2019",
doi = "10.1093/schbul/sbz021.268",
language = "English",
volume = "45",
pages = "S198--S199",
journal = "Schizophrenia Bulletin",
issn = "0586-7614",
publisher = "Oxford University Press",
number = "Suppl. 2",

}

RIS

TY - ABST

T1 - O12.4. EFFECTS OF THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST EXENATIDE ON BONE STATUS IN OBESE, NON-DIABETIC, ANTIPSYCHOTIC-TREATED SCHIZOPHRENIA SPECTRUM PATIENTS

AU - Eriksson, Robert

AU - Broberg, Brian V

AU - Ishoy, Pelle Lau

AU - Bak, Nikolaj

AU - Andersen, Ulrik B

AU - Jørgensen, Niklas R

AU - Knop, Filip K

AU - Ebdrup, Bjorn

PY - 2019

Y1 - 2019

U2 - 10.1093/schbul/sbz021.268

DO - 10.1093/schbul/sbz021.268

M3 - Conference abstract in journal

VL - 45

SP - S198-S199

JO - Schizophrenia Bulletin

JF - Schizophrenia Bulletin

SN - 0586-7614

IS - Suppl. 2

ER -

ID: 237801066